SK
Sandeep Kumar
Also known as: Kumar, S
University of Illinois at Chicago, University of Illinois Chicago, Roswell Park Cancer Institute
0000-0002-2376-6469
Employment
-
University of Illinois at Chicago Assistant Professor (Tenure Track)2022 - Present
-
University of Illinois Chicago Postdoctoral Research Associate/RAP2016 - 2022
-
Roswell Park Cancer Institute Predoctoral/Post-Doctoral Fellow2013 - 2016
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (22)
- Calcium channel blockers potentiate gemcitabine chemotherapy in pancreatic cancer Save
- Mixed lineage kinase 3 and CD70 cooperation sensitize trastuzumab-resistant HER2 + breast cancer by ceramide-loaded nanoparticles Save
- MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3 Save
- Tumor-infiltrating CD8+ T cell antitumor efficacy and exhaustion: molecular insights Save
- The regulatory function of mixed lineage kinase 3 in tumor and host immunity. Save
- Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8+ T cells. Save
- Long-Term Gemcitabine Treatment Reshapes the Pancreatic Tumor Microenvironment and Sensitizes Murine Carcinoma to Combination Immunotherapy. Save
- Mixed lineage kinase 3 inhibition induces T cell activation and cytotoxicity. Save
- Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in Cancer. Save
- Hsp60 and IL-8 axis promotes apoptosis resistance in cancer. Save